- Recommendation ID
- NG130/3
- Question
What is the clinical and cost effectiveness of prednisolone, budesonide, and beclometasone in addition to aminosalicylates compared with each other and with aminosalicylate monotherapy for the induction of remission for people with mild-to-moderate ulcerative colitis?
- Any explanatory notes
(if applicable) To find out why the committee made the research recommendation on corticosteroids for the induction of remission in mild-to-moderate ulcerative colitis see rationale and impact.
Source guidance details
- Comes from guidance
- Ulcerative colitis: management
- Number
- NG130
- Date issued
- May 2019
Other details
| Is this a recommendation for the use of a technology only in the context of research? | No |
| Is it a recommendation that suggests collection of data or the establishment of a register? | No |
| Last Reviewed | 03/05/2019 |